Immuno-Oncology 2018 Conference

We are proud to present the inaugural Immuno-Oncology Conference, taking place in London on the 26th-27th of September, 2018.

Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies.

This event will draw together different, key facets of the rapidly evolving field to propagate invigorating and thought-provoking discussions between industry leaders and inform and update delegates on current key areas for development, on future potential therapies advancements and provide revisions of regulations.

The Immuno-Oncology Conference will focus on a few key areas of the field with a representation of the whole industry under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.

Benefits of Attending

• Learn about targeting immune checkpoints with Humabody VH Therapeutics
• Discover the recent advances in providing durable disease control with Keytruda as an anti-cancer therapy
• Discuss the tumour mutation burden and the potential of its use as an indication of treatment choice
• Develop an understanding of unwanted immunogenicity and functionality testing of immuno-oncology drugs
• Gain insight into new techniques, such as the emerging applications of liquid biopsies, in Immuno-Oncology

At our Immuno-Oncology Conference you will get:

• Networking: We keep networking at the forefront when it comes to our attendees. 5+ hours of pure networking guaranteed
• Agenda: A valuable time is spent to discover the latest trends and hottest topics in the industry to provide the best possible agenda for our attendees. 15+ engaging presentations/case studies/keynote addresses
• Speakers: Top representation of industry leaders. 15+ leading experts in Immuno-Oncology field
• Workshops: Carefully selected topics for further on-sight training. 2 pre-conference workshops with in-depth knowledge on specific topics

Who should attend

Directors, senior scientists, project leaders, research directors of

• Immuno-oncology
• vaccine development
• oncology
• molecular medicine
• immunobiology

Plus Two Interactive Half-Day Pre-Conference Workshops | Tuesday 25th September 2018

Workshop A: Strategic Competitive Intelligence in the Immuno-Oncology space
Workshop Leaders: Timos Papagatsias, CEO, LucidQuest Ventures
08.30 - 12.30

Workshop B: Could the Microbiome boost cancer immunotherapy?
Workshop Leaders:Shahram Lavasani, CEO, ImmuneBiotech
Ramin Massoumi, Principal Investigator, Lund University